Intelligent Medication Mixing System

Publication ID: 24-11857498_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Medication Mixing System,” Published Technical Disclosure No. 24-11857498_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857498_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,498.

Summary of the Inventive Concept

A revolutionary medication mixing system integrating AI, IoT, blockchain, and novel materials to optimize and secure the mixing process, providing enhanced patient safety and treatment outcomes.

Background and Problem Solved

The original syringe system patent addressed the need for a reliable and efficient way to mix separate medication components. However, it lacked the integration of advanced technologies to further enhance the mixing process. This new inventive concept solves the problem of suboptimal mixing ratios, lack of real-time monitoring, and potential counterfeiting by incorporating AI-powered mixing algorithms, IoT sensors, blockchain tracking, and novel materials with enhanced mixing properties.

Detailed Description of the Inventive Concept

The Intelligent Medication Mixing System consists of a first syringe and a second syringe, mechanically coupled to mix a female portion and a male portion of the medication. The system is configured to optimize the mixing ratio based on real-time patient data using an AI-powered mixing algorithm. IoT sensors monitor and control the mixing process in real-time, ensuring accurate and consistent results. A blockchain-based tracking system ensures the authenticity and integrity of the mixed medication. Additionally, the system incorporates a novel material with enhanced mixing properties to further improve the mixing process. The system also includes an AI-powered analytics platform and a user interface that provides real-time feedback and guidance to the user.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and novel materials, which are not obvious from the original patent. The combination of these technologies provides a synergistic effect, resulting in a more efficient, accurate, and secure medication mixing system.

Alternative Embodiments and Variations

Alternative embodiments of the Intelligent Medication Mixing System could include the use of different AI algorithms, varying IoT sensor configurations, or alternative blockchain platforms. Additionally, the system could be adapted for use with different types of medications or in various healthcare settings.

Potential Commercial Applications and Market

The Intelligent Medication Mixing System has significant commercial potential in the pharmaceutical and healthcare industries, particularly in hospitals, clinics, and pharmacies. The system's ability to optimize mixing ratios, ensure authenticity, and provide real-time feedback could lead to improved patient outcomes, reduced costs, and increased efficiency.

CPC Classifications

SectionClassGroup
A A61 A61J1/2089
A A61 A61M5/1782
A A61 A61M5/3135
A A61 A61M2205/02

Field of Art

Medical Device Technology, specifically pharmaceutical delivery systems and syringe design, involving expertise in materials science, mechanical engineering, and medical device integration

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, 3-5 years professional experience, familiar with pharmaceutical mixing technologies, materials compatibility, and emerging medical device integration techniques

Obviousness Rationale

A PHOSITA would recognize that the proposed intelligent medication mixing system represents a predictable technological extension of the existing syringe coupling system, applying known digital technologies to enhance functionality while maintaining the core mechanical coupling mechanism of the source patent. The integration of AI, IoT, and blockchain represents standard technological augmentation strategies commonly applied to medical devices to improve precision, tracking, and patient safety. These technological additions would be considered routine optimization by a skilled practitioner seeking to enhance existing medical delivery systems.

Obvious Combinations & Variations

Source Patent Element
Two-component syringe system with mechanical coupling mechanism
PTD Variation
Adding AI-powered mixing algorithm to optimize medication mixing ratio
Obviousness Reasoning
Applying computational optimization to medical mixing is a known technique, representing a predictable application of machine learning to improve precision in pharmaceutical delivery
Source Patent Element
Syringe constructed from specific polymers like polypropylene
PTD Variation
Introducing novel material with enhanced mixing properties
Obviousness Reasoning
Material science optimization is a standard design approach, with finite identifiable improvements in polymer chemistry being obvious to a skilled practitioner
Source Patent Element
Mechanical coupling between female and male syringe components
PTD Variation
Integrating IoT sensors to monitor and control mixing process in real-time
Obviousness Reasoning
Adding sensor-based monitoring to medical devices is a well-established technique for improving procedural accuracy and safety
Source Patent Element
Two-component medication mixing system
PTD Variation
Blockchain-based tracking system ensuring medication authenticity
Obviousness Reasoning
Implementing digital authentication and tracking is a standard technological enhancement for improving medical device security and traceability
Source Patent Element
Syringe system for medication mixing
PTD Variation
AI-powered analytics platform with user interface providing real-time feedback
Obviousness Reasoning
User interface and analytics integration represents a predictable technological evolution for improving medical device usability and patient outcomes
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857498 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed intelligent medication mixing system obvious, as the claimed innovations represent predictable technological extensions utilizing standard integration techniques in medical device design, thereby rendering subsequent claims covering similar technological combinations anticipated and non-patentable.

Original Patent Information

Patent NumberUS 11,857,498
TitleSyringe system
Assignee(s)Indivior UK Limited